TNFRSF11A and diabetic kidney disease: Corrigendum to "Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-<i>κ</i>B Pathway in Type 2 Diabetic db/db Mice".